Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoplastic Left Heart Syndrome | 22 | 2024 | 594 | 1.970 |
Why?
|
Shock, Cardiogenic | 40 | 2011 | 709 | 1.920 |
Why?
|
Heart Defects, Congenital | 39 | 2024 | 4671 | 1.730 |
Why?
|
Norwood Procedures | 15 | 2019 | 192 | 1.500 |
Why?
|
Fontan Procedure | 19 | 2023 | 796 | 1.480 |
Why?
|
Tetralogy of Fallot | 11 | 2024 | 618 | 1.430 |
Why?
|
Cardiomyopathy, Dilated | 17 | 2017 | 829 | 1.410 |
Why?
|
Heart Ventricles | 33 | 2023 | 3807 | 1.400 |
Why?
|
Cardiac Surgical Procedures | 23 | 2024 | 3627 | 1.120 |
Why?
|
Myocardial Revascularization | 29 | 2011 | 790 | 1.060 |
Why?
|
Pulmonary Valve | 8 | 2023 | 411 | 1.060 |
Why?
|
Blalock-Taussig Procedure | 9 | 2019 | 60 | 1.050 |
Why?
|
Marfan Syndrome | 8 | 2022 | 236 | 1.020 |
Why?
|
Registries | 51 | 2024 | 8224 | 0.910 |
Why?
|
Aortic Valve Insufficiency | 5 | 2021 | 576 | 0.840 |
Why?
|
Heart Transplantation | 25 | 2023 | 3233 | 0.810 |
Why?
|
Infant | 101 | 2024 | 36192 | 0.770 |
Why?
|
Ventricular Function, Left | 21 | 2024 | 3879 | 0.760 |
Why?
|
Mitral Valve Insufficiency | 9 | 2024 | 1400 | 0.750 |
Why?
|
Echocardiography | 30 | 2023 | 4989 | 0.740 |
Why?
|
Ventricular Dysfunction, Left | 20 | 2021 | 2118 | 0.720 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2021 | 353 | 0.690 |
Why?
|
Atenolol | 6 | 2020 | 99 | 0.680 |
Why?
|
Cardiomyopathy, Hypertrophic | 8 | 2018 | 1310 | 0.670 |
Why?
|
Child, Preschool | 96 | 2024 | 42230 | 0.620 |
Why?
|
Losartan | 6 | 2020 | 265 | 0.610 |
Why?
|
Child | 118 | 2024 | 80153 | 0.610 |
Why?
|
Sudden Infant Death | 8 | 2024 | 292 | 0.580 |
Why?
|
Heart Diseases | 9 | 2024 | 2781 | 0.580 |
Why?
|
Hypertension, Pulmonary | 3 | 2022 | 1578 | 0.560 |
Why?
|
Angioplasty, Balloon, Coronary | 17 | 2012 | 1725 | 0.530 |
Why?
|
Heart Valve Diseases | 2 | 2020 | 1027 | 0.520 |
Why?
|
Pulmonary Artery | 10 | 2022 | 1927 | 0.510 |
Why?
|
Heart Valve Prosthesis Implantation | 7 | 2023 | 1553 | 0.500 |
Why?
|
Pulmonary Valve Insufficiency | 3 | 2023 | 140 | 0.490 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 5 | 2011 | 536 | 0.480 |
Why?
|
Coronary Artery Bypass | 17 | 2014 | 2188 | 0.460 |
Why?
|
Palliative Care | 11 | 2024 | 3598 | 0.460 |
Why?
|
Fetal Diseases | 4 | 2022 | 913 | 0.450 |
Why?
|
Ventricular Dysfunction, Right | 5 | 2021 | 628 | 0.450 |
Why?
|
Infant, Newborn | 55 | 2024 | 26198 | 0.450 |
Why?
|
Aortic Valve Stenosis | 7 | 2022 | 2001 | 0.440 |
Why?
|
Myocardial Infarction | 39 | 2012 | 11460 | 0.440 |
Why?
|
Retrospective Studies | 76 | 2024 | 80636 | 0.420 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 1462 | 0.410 |
Why?
|
Stroke Volume | 19 | 2022 | 5496 | 0.400 |
Why?
|
Treatment Outcome | 73 | 2024 | 64680 | 0.390 |
Why?
|
Heart Septal Defects, Ventricular | 4 | 2022 | 477 | 0.380 |
Why?
|
Humans | 254 | 2024 | 761504 | 0.370 |
Why?
|
Intra-Aortic Balloon Pumping | 13 | 2011 | 223 | 0.360 |
Why?
|
Male | 178 | 2024 | 360804 | 0.360 |
Why?
|
Peptic Ulcer | 2 | 2024 | 217 | 0.360 |
Why?
|
Female | 182 | 2024 | 392644 | 0.360 |
Why?
|
Postoperative Hemorrhage | 3 | 2019 | 415 | 0.360 |
Why?
|
Partial Thromboplastin Time | 3 | 2021 | 204 | 0.350 |
Why?
|
Hemodynamics | 13 | 2023 | 4159 | 0.350 |
Why?
|
Postoperative Complications | 22 | 2021 | 15631 | 0.350 |
Why?
|
Ventricular Remodeling | 6 | 2023 | 1267 | 0.340 |
Why?
|
Quality of Life | 9 | 2023 | 13367 | 0.340 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 5 | 2020 | 431 | 0.340 |
Why?
|
Adolescent | 74 | 2024 | 88319 | 0.330 |
Why?
|
Ventricular Function | 7 | 2012 | 406 | 0.320 |
Why?
|
Hospital Mortality | 21 | 2018 | 5294 | 0.320 |
Why?
|
Social Class | 5 | 2023 | 2004 | 0.310 |
Why?
|
Thrombolytic Therapy | 17 | 2010 | 2064 | 0.300 |
Why?
|
Blood Coagulation | 3 | 2019 | 1154 | 0.300 |
Why?
|
Heart Neoplasms | 2 | 2021 | 362 | 0.290 |
Why?
|
Aortic Diseases | 3 | 2020 | 735 | 0.290 |
Why?
|
Thrombelastography | 2 | 2021 | 187 | 0.290 |
Why?
|
Heart Septal Defects | 2 | 2023 | 190 | 0.290 |
Why?
|
Time Factors | 43 | 2024 | 39967 | 0.280 |
Why?
|
Exercise Tolerance | 3 | 2019 | 836 | 0.280 |
Why?
|
Heparin | 3 | 2019 | 1634 | 0.280 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2010 | 664 | 0.280 |
Why?
|
Bioprosthesis | 3 | 2021 | 591 | 0.270 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2022 | 1241 | 0.270 |
Why?
|
Developmental Disabilities | 6 | 2020 | 1509 | 0.260 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 3 | 2020 | 30 | 0.260 |
Why?
|
Age Factors | 26 | 2020 | 18395 | 0.260 |
Why?
|
Length of Stay | 16 | 2022 | 6425 | 0.260 |
Why?
|
Predictive Value of Tests | 15 | 2024 | 15266 | 0.260 |
Why?
|
Serotonin | 4 | 2024 | 1041 | 0.260 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2005 | 82 | 0.250 |
Why?
|
Nerve Block | 2 | 2024 | 706 | 0.250 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2018 | 451 | 0.250 |
Why?
|
Troponin | 2 | 2020 | 502 | 0.250 |
Why?
|
Reoperation | 10 | 2023 | 4303 | 0.240 |
Why?
|
Magnetic Resonance Imaging, Cine | 6 | 2021 | 1050 | 0.240 |
Why?
|
Kaplan-Meier Estimate | 15 | 2020 | 6484 | 0.240 |
Why?
|
Drug Resistance | 1 | 2010 | 1596 | 0.240 |
Why?
|
Nervous System | 2 | 2020 | 545 | 0.230 |
Why?
|
Leukomalacia, Periventricular | 3 | 2013 | 184 | 0.230 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15842 | 0.230 |
Why?
|
Follow-Up Studies | 35 | 2022 | 39106 | 0.230 |
Why?
|
Enalapril | 3 | 2011 | 312 | 0.230 |
Why?
|
Ventricular Dysfunction | 2 | 2018 | 144 | 0.220 |
Why?
|
Prospective Studies | 55 | 2024 | 54425 | 0.220 |
Why?
|
Survival Rate | 22 | 2021 | 12725 | 0.220 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2024 | 144 | 0.220 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 6 | 2022 | 1516 | 0.220 |
Why?
|
Heart Valve Prosthesis | 4 | 2021 | 1462 | 0.220 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1304 | 0.220 |
Why?
|
14-3-3 Proteins | 1 | 2024 | 220 | 0.210 |
Why?
|
Drug-Eluting Stents | 4 | 2012 | 681 | 0.210 |
Why?
|
Risk Factors | 50 | 2024 | 74206 | 0.210 |
Why?
|
Risk Assessment | 26 | 2024 | 23995 | 0.210 |
Why?
|
Mitral Valve | 2 | 2024 | 1465 | 0.210 |
Why?
|
Endocardial Fibroelastosis | 1 | 2023 | 56 | 0.210 |
Why?
|
Educational Status | 3 | 2020 | 2522 | 0.210 |
Why?
|
Cost of Illness | 2 | 2023 | 1936 | 0.200 |
Why?
|
Proportional Hazards Models | 20 | 2020 | 12463 | 0.200 |
Why?
|
Heart-Assist Devices | 3 | 2024 | 1287 | 0.200 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2018 | 607 | 0.200 |
Why?
|
Cardiopulmonary Bypass | 2 | 2018 | 1092 | 0.200 |
Why?
|
Immunologic Factors | 2 | 2010 | 1589 | 0.200 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2022 | 273 | 0.200 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2005 | 352 | 0.190 |
Why?
|
Thrombosis | 4 | 2019 | 2942 | 0.190 |
Why?
|
Anemia, Sickle Cell | 10 | 2001 | 1063 | 0.190 |
Why?
|
Heart Failure | 13 | 2024 | 11669 | 0.180 |
Why?
|
Fathers | 1 | 2024 | 376 | 0.180 |
Why?
|
Pulmonary Circulation | 3 | 2020 | 737 | 0.180 |
Why?
|
Prognosis | 25 | 2024 | 29625 | 0.180 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 52 | 0.180 |
Why?
|
Cardiomyopathies | 4 | 2021 | 1964 | 0.180 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
Factor Xa | 2 | 2018 | 167 | 0.180 |
Why?
|
Parents | 4 | 2023 | 3563 | 0.170 |
Why?
|
Ebstein Anomaly | 1 | 2021 | 105 | 0.170 |
Why?
|
Encephalitis | 1 | 2024 | 438 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2244 | 0.170 |
Why?
|
Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2020 | 51 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Anti-Ulcer Agents | 1 | 2020 | 112 | 0.170 |
Why?
|
Coronary Angiography | 16 | 2009 | 4471 | 0.170 |
Why?
|
Recovery of Function | 6 | 2018 | 2979 | 0.160 |
Why?
|
Down Syndrome | 2 | 2022 | 901 | 0.160 |
Why?
|
Fibroma | 1 | 2021 | 190 | 0.160 |
Why?
|
Young Adult | 25 | 2024 | 59243 | 0.160 |
Why?
|
North America | 8 | 2016 | 1276 | 0.160 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 166 | 0.160 |
Why?
|
Ventricular Function, Right | 5 | 2023 | 617 | 0.160 |
Why?
|
Multivariate Analysis | 14 | 2017 | 12059 | 0.160 |
Why?
|
Heart Valves | 1 | 2020 | 284 | 0.160 |
Why?
|
Anticoagulants | 3 | 2019 | 4812 | 0.160 |
Why?
|
Diastole | 2 | 2022 | 782 | 0.150 |
Why?
|
Systole | 2 | 2021 | 936 | 0.150 |
Why?
|
Protamines | 1 | 2018 | 112 | 0.150 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26125 | 0.150 |
Why?
|
Reference Values | 7 | 2023 | 4920 | 0.150 |
Why?
|
Vasodilator Agents | 1 | 2022 | 973 | 0.150 |
Why?
|
Coronary Artery Disease | 7 | 2012 | 6403 | 0.150 |
Why?
|
Diabetes Complications | 4 | 2012 | 1315 | 0.150 |
Why?
|
Transposition of Great Vessels | 1 | 2022 | 581 | 0.150 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2017 | 322 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2022 | 10209 | 0.150 |
Why?
|
Diabetic Angiopathies | 2 | 2012 | 803 | 0.140 |
Why?
|
Fetus | 2 | 2022 | 1863 | 0.140 |
Why?
|
Death, Sudden, Cardiac | 2 | 2018 | 1555 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1116 | 0.140 |
Why?
|
Reproducibility of Results | 15 | 2024 | 20098 | 0.140 |
Why?
|
Medulla Oblongata | 3 | 2005 | 248 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2021 | 495 | 0.140 |
Why?
|
Fetal Heart | 1 | 2018 | 281 | 0.140 |
Why?
|
Echocardiography, Doppler | 4 | 2014 | 897 | 0.140 |
Why?
|
Critical Illness | 4 | 2024 | 2723 | 0.130 |
Why?
|
Cohort Studies | 18 | 2022 | 41487 | 0.130 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1515 | 0.130 |
Why?
|
Aortic Valve | 3 | 2021 | 1955 | 0.130 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1739 | 0.130 |
Why?
|
United States | 32 | 2024 | 72334 | 0.130 |
Why?
|
Hypoxia, Brain | 2 | 2013 | 138 | 0.130 |
Why?
|
Child Development | 4 | 2020 | 2306 | 0.130 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3889 | 0.130 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 22 | 0.130 |
Why?
|
Mothers | 6 | 2023 | 2198 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 722 | 0.130 |
Why?
|
Survival Analysis | 14 | 2018 | 10090 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2018 | 516 | 0.120 |
Why?
|
Clinical Trials as Topic | 5 | 2013 | 8002 | 0.120 |
Why?
|
Brain Stem | 6 | 2024 | 858 | 0.120 |
Why?
|
Drug Monitoring | 2 | 2018 | 962 | 0.120 |
Why?
|
Gastroesophageal Reflux | 1 | 2022 | 819 | 0.120 |
Why?
|
Adult | 48 | 2024 | 221177 | 0.120 |
Why?
|
Electric Countershock | 1 | 2018 | 533 | 0.120 |
Why?
|
Aorta | 3 | 2022 | 2042 | 0.120 |
Why?
|
Coronary Vessels | 3 | 2011 | 3096 | 0.120 |
Why?
|
Dilatation, Pathologic | 4 | 2020 | 527 | 0.120 |
Why?
|
Heart Block | 1 | 2016 | 386 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2024 | 5247 | 0.120 |
Why?
|
Coronary Circulation | 3 | 2018 | 1569 | 0.120 |
Why?
|
Sarcomeres | 1 | 2017 | 368 | 0.120 |
Why?
|
Emergency Treatment | 4 | 2005 | 496 | 0.110 |
Why?
|
Logistic Models | 11 | 2021 | 13255 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 961 | 0.110 |
Why?
|
Blood Platelets | 1 | 2024 | 2479 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 1039 | 0.110 |
Why?
|
Canada | 7 | 2017 | 2122 | 0.110 |
Why?
|
Health Status | 6 | 2018 | 4077 | 0.110 |
Why?
|
Heart Bypass, Right | 2 | 2010 | 75 | 0.110 |
Why?
|
Myocarditis | 3 | 2011 | 788 | 0.110 |
Why?
|
Infant, Premature, Diseases | 2 | 2013 | 710 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2018 | 1723 | 0.100 |
Why?
|
Hospitals, Pediatric | 4 | 2018 | 1860 | 0.100 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2012 | 61 | 0.100 |
Why?
|
Incidence | 18 | 2017 | 21353 | 0.100 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 740 | 0.100 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2011 | 69 | 0.100 |
Why?
|
Thoracic Arteries | 1 | 2011 | 40 | 0.100 |
Why?
|
Residence Characteristics | 2 | 2020 | 2093 | 0.100 |
Why?
|
Noonan Syndrome | 1 | 2012 | 120 | 0.100 |
Why?
|
Exercise Test | 7 | 2018 | 2127 | 0.100 |
Why?
|
Hemorrhage | 2 | 2021 | 3424 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2020 | 0.100 |
Why?
|
Waiting Lists | 2 | 2022 | 765 | 0.090 |
Why?
|
Contrast Media | 2 | 2021 | 5311 | 0.090 |
Why?
|
Psychomotor Disorders | 1 | 2012 | 149 | 0.090 |
Why?
|
Income | 2 | 2020 | 1877 | 0.090 |
Why?
|
Cause of Death | 6 | 2024 | 3683 | 0.090 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 69 | 0.090 |
Why?
|
Child, Hospitalized | 2 | 2024 | 182 | 0.090 |
Why?
|
Quality Improvement | 2 | 2024 | 3801 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3808 | 0.090 |
Why?
|
Vascular Grafting | 1 | 2012 | 162 | 0.090 |
Why?
|
Afghan Campaign 2001- | 1 | 2011 | 298 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2011 | 168 | 0.090 |
Why?
|
Longitudinal Studies | 11 | 2023 | 14605 | 0.090 |
Why?
|
Middle Aged | 47 | 2024 | 220895 | 0.090 |
Why?
|
Cardiology | 2 | 2018 | 1656 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1380 | 0.080 |
Why?
|
Aortic Aneurysm | 1 | 2014 | 648 | 0.080 |
Why?
|
Combat Disorders | 1 | 2011 | 301 | 0.080 |
Why?
|
Temporal Lobe | 1 | 2017 | 1695 | 0.080 |
Why?
|
Aged | 49 | 2021 | 169289 | 0.080 |
Why?
|
Physicians | 2 | 2018 | 4591 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1924 | 0.080 |
Why?
|
Double-Blind Method | 6 | 2020 | 12341 | 0.080 |
Why?
|
Patient Selection | 8 | 2020 | 4244 | 0.080 |
Why?
|
Health Resources | 1 | 2015 | 935 | 0.080 |
Why?
|
Pregnancy | 11 | 2022 | 29874 | 0.080 |
Why?
|
Hemophilia A | 4 | 1997 | 360 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2243 | 0.080 |
Why?
|
Disease-Free Survival | 6 | 2018 | 6814 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17904 | 0.080 |
Why?
|
Clinical Competence | 2 | 2017 | 4792 | 0.080 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2219 | 0.080 |
Why?
|
Electrocardiography | 7 | 2017 | 6377 | 0.080 |
Why?
|
Gestational Age | 6 | 2021 | 3577 | 0.080 |
Why?
|
Heart Rate | 5 | 2021 | 4195 | 0.080 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1490 | 0.080 |
Why?
|
Phenotype | 6 | 2020 | 16591 | 0.080 |
Why?
|
ROC Curve | 3 | 2013 | 3579 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3537 | 0.070 |
Why?
|
Hospitalization | 4 | 2024 | 10723 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4234 | 0.070 |
Why?
|
Situs Inversus | 1 | 2007 | 63 | 0.070 |
Why?
|
Databases, Factual | 6 | 2021 | 7967 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 3 | 2022 | 1755 | 0.070 |
Why?
|
Preoperative Care | 2 | 2018 | 2242 | 0.070 |
Why?
|
Multicenter Studies as Topic | 3 | 2006 | 1702 | 0.070 |
Why?
|
Oxygen Consumption | 4 | 2019 | 1866 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 737 | 0.070 |
Why?
|
Chemical Warfare | 1 | 1986 | 18 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2020 | 2850 | 0.070 |
Why?
|
Gadolinium | 2 | 2021 | 960 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 952 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2014 | 3416 | 0.060 |
Why?
|
Terminal Care | 1 | 2018 | 1760 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2024 | 2115 | 0.060 |
Why?
|
Protective Clothing | 1 | 1986 | 103 | 0.060 |
Why?
|
Intraoperative Complications | 2 | 1995 | 1165 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4227 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2007 | 385 | 0.060 |
Why?
|
Receptors, Serotonin | 3 | 2003 | 208 | 0.060 |
Why?
|
beta-Thalassemia | 4 | 2000 | 236 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2018 | 5112 | 0.060 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2008 | 267 | 0.060 |
Why?
|
Gram-Negative Bacteria | 1 | 2007 | 272 | 0.060 |
Why?
|
Puberty, Delayed | 2 | 1997 | 121 | 0.060 |
Why?
|
Research Design | 6 | 2015 | 6180 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 12 | 2021 | 36426 | 0.060 |
Why?
|
Odds Ratio | 6 | 2020 | 9646 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3357 | 0.060 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 368 | 0.060 |
Why?
|
Career Choice | 1 | 2011 | 756 | 0.060 |
Why?
|
Neopterin | 1 | 2024 | 56 | 0.060 |
Why?
|
Abnormalities, Multiple | 2 | 2012 | 1423 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1792 | 0.060 |
Why?
|
Risk Management | 1 | 2007 | 558 | 0.060 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2011 | 696 | 0.060 |
Why?
|
Pediatrics | 3 | 2015 | 3589 | 0.060 |
Why?
|
Pilot Projects | 3 | 2024 | 8631 | 0.060 |
Why?
|
Growth Disorders | 3 | 2011 | 655 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1767 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2021 | 1017 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1998 | 0.060 |
Why?
|
Disease Progression | 7 | 2021 | 13506 | 0.060 |
Why?
|
Miniaturization | 1 | 2024 | 153 | 0.060 |
Why?
|
Perceptual Disorders | 1 | 1986 | 198 | 0.060 |
Why?
|
Brain | 5 | 2017 | 27112 | 0.060 |
Why?
|
Intensive Care Units | 4 | 2022 | 3745 | 0.050 |
Why?
|
Thoracic Duct | 1 | 2023 | 64 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 794 | 0.050 |
Why?
|
Cerebral Ventricles | 2 | 2005 | 542 | 0.050 |
Why?
|
Propensity Score | 2 | 2023 | 1913 | 0.050 |
Why?
|
Cataract Extraction | 1 | 1987 | 467 | 0.050 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2011 | 352 | 0.050 |
Why?
|
Emergency Medical Services | 2 | 2005 | 1923 | 0.050 |
Why?
|
Ulcer | 1 | 2024 | 204 | 0.050 |
Why?
|
Algorithms | 4 | 2022 | 14031 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11903 | 0.050 |
Why?
|
Morphine Derivatives | 1 | 2021 | 42 | 0.050 |
Why?
|
Autoradiography | 5 | 2003 | 728 | 0.050 |
Why?
|
Autopsy | 2 | 2017 | 1008 | 0.050 |
Why?
|
Morbidity | 2 | 2021 | 1750 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2011 | 2161 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2011 | 1418 | 0.050 |
Why?
|
Respiratory Center | 1 | 2001 | 18 | 0.050 |
Why?
|
Bacteremia | 2 | 2007 | 979 | 0.050 |
Why?
|
Case-Control Studies | 7 | 2024 | 22176 | 0.050 |
Why?
|
Heart Atria | 1 | 2007 | 1345 | 0.050 |
Why?
|
Coitus | 2 | 2007 | 132 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2015 | 678 | 0.050 |
Why?
|
Boston | 3 | 2018 | 9326 | 0.050 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2001 | 69 | 0.050 |
Why?
|
Ventricular Septal Rupture | 1 | 2000 | 17 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 348 | 0.050 |
Why?
|
Cerebral Palsy | 1 | 2005 | 474 | 0.050 |
Why?
|
Interviews as Topic | 3 | 2018 | 2696 | 0.040 |
Why?
|
Linear Models | 3 | 2018 | 5871 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5440 | 0.040 |
Why?
|
alpha-Thalassemia | 3 | 1998 | 52 | 0.040 |
Why?
|
Cardiotonic Agents | 3 | 2010 | 539 | 0.040 |
Why?
|
Graft Survival | 2 | 2023 | 3819 | 0.040 |
Why?
|
Data Collection | 3 | 2013 | 3322 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2005 | 621 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4853 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6596 | 0.040 |
Why?
|
Quinuclidinyl Benzilate | 2 | 1998 | 19 | 0.040 |
Why?
|
Neurons | 2 | 2012 | 9463 | 0.040 |
Why?
|
Fibrinolytic Agents | 3 | 2012 | 2084 | 0.040 |
Why?
|
Patient Discharge | 2 | 2024 | 3443 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2012 | 4330 | 0.040 |
Why?
|
Hot Temperature | 1 | 1986 | 1440 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 282 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 733 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 322 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2020 | 361 | 0.040 |
Why?
|
Receptors, Muscarinic | 2 | 1998 | 157 | 0.040 |
Why?
|
Image Enhancement | 3 | 2012 | 2885 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1458 | 0.040 |
Why?
|
Observer Variation | 3 | 2020 | 2606 | 0.040 |
Why?
|
Hemoglobin C Disease | 2 | 1995 | 8 | 0.040 |
Why?
|
Genotype | 5 | 2020 | 12990 | 0.040 |
Why?
|
Receptors, Nicotinic | 2 | 1998 | 495 | 0.040 |
Why?
|
Australia | 2 | 2018 | 1250 | 0.040 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2021 | 410 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 515 | 0.040 |
Why?
|
Sex Distribution | 3 | 2014 | 2281 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Patient Readmission | 2 | 2024 | 3270 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2007 | 2180 | 0.040 |
Why?
|
Blood Pressure | 4 | 2007 | 8481 | 0.040 |
Why?
|
Receptors, Neurotransmitter | 1 | 1998 | 174 | 0.040 |
Why?
|
Veterans | 1 | 2011 | 2647 | 0.040 |
Why?
|
Receptors, Kainic Acid | 1 | 1997 | 91 | 0.040 |
Why?
|
Visual Perception | 1 | 1986 | 1387 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 1997 | 26 | 0.040 |
Why?
|
Spinal Cord | 1 | 2005 | 1818 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2018 | 246 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 5840 | 0.040 |
Why?
|
Prevalence | 6 | 2015 | 15732 | 0.040 |
Why?
|
Infant Mortality | 2 | 2012 | 759 | 0.040 |
Why?
|
Pericardium | 1 | 2021 | 675 | 0.040 |
Why?
|
Up-Regulation | 2 | 2020 | 4124 | 0.040 |
Why?
|
Fetal Therapies | 1 | 2018 | 101 | 0.030 |
Why?
|
Lysergic Acid Diethylamide | 3 | 2003 | 47 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6310 | 0.030 |
Why?
|
Brain Damage, Chronic | 2 | 2012 | 267 | 0.030 |
Why?
|
Military Personnel | 1 | 1986 | 1246 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2016 | 1371 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2017 | 211 | 0.030 |
Why?
|
Causality | 2 | 2016 | 1242 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
Jugular Veins | 1 | 2017 | 210 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1257 | 0.030 |
Why?
|
Mesencephalon | 1 | 1998 | 332 | 0.030 |
Why?
|
Aldosterone | 2 | 2011 | 870 | 0.030 |
Why?
|
Patient Transfer | 1 | 2003 | 794 | 0.030 |
Why?
|
Cattle | 1 | 2021 | 3849 | 0.030 |
Why?
|
Amniotic Fluid | 1 | 2018 | 378 | 0.030 |
Why?
|
Neuropsychological Tests | 3 | 2014 | 7045 | 0.030 |
Why?
|
Pregnancy Outcome | 2 | 2018 | 2921 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2012 | 5777 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2018 | 578 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 267 | 0.030 |
Why?
|
Cervix Mucus | 1 | 1995 | 17 | 0.030 |
Why?
|
Comorbidity | 5 | 2012 | 10508 | 0.030 |
Why?
|
Platelet Transfusion | 1 | 2018 | 297 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1265 | 0.030 |
Why?
|
Malformations of Cortical Development | 1 | 2017 | 176 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2010 | 774 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3429 | 0.030 |
Why?
|
Prenatal Care | 1 | 2022 | 1139 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
Diuretics | 2 | 2010 | 610 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 1997 | 960 | 0.030 |
Why?
|
Exercise | 2 | 2008 | 5890 | 0.030 |
Why?
|
Survivors | 2 | 2020 | 2371 | 0.030 |
Why?
|
Body Height | 3 | 2014 | 1570 | 0.030 |
Why?
|
Stroke | 5 | 2012 | 9757 | 0.030 |
Why?
|
Health Education | 1 | 2021 | 1052 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1998 | 436 | 0.030 |
Why?
|
Oximetry | 1 | 2017 | 459 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 1999 | 983 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2011 | 4575 | 0.030 |
Why?
|
Pain Measurement | 1 | 2024 | 3550 | 0.030 |
Why?
|
Cerebrovascular Disorders | 2 | 1998 | 1474 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2880 | 0.030 |
Why?
|
Hemoglobin SC Disease | 1 | 1993 | 23 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2000 | 980 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2013 | 6228 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 9000 | 0.030 |
Why?
|
Coronary Disease | 1 | 2008 | 5914 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2115 | 0.030 |
Why?
|
Australasia | 1 | 2012 | 21 | 0.030 |
Why?
|
Infant, Premature | 2 | 2013 | 2107 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3769 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 1998 | 488 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2645 | 0.030 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1994 | 179 | 0.030 |
Why?
|
Urban Health | 1 | 1995 | 532 | 0.030 |
Why?
|
South America | 1 | 2012 | 179 | 0.030 |
Why?
|
Achievement | 1 | 1994 | 288 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30052 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 1997 | 642 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.020 |
Why?
|
Tissue Donors | 1 | 2022 | 2331 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12974 | 0.020 |
Why?
|
Poverty | 1 | 2023 | 2698 | 0.020 |
Why?
|
Stents | 1 | 2003 | 3179 | 0.020 |
Why?
|
Emergencies | 3 | 2006 | 1217 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2017 | 851 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2018 | 1298 | 0.020 |
Why?
|
Metabolism, Inborn Errors | 1 | 2013 | 284 | 0.020 |
Why?
|
Osteonecrosis | 1 | 1993 | 229 | 0.020 |
Why?
|
Humerus | 1 | 1993 | 272 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2001 | 2639 | 0.020 |
Why?
|
Child Abuse, Sexual | 1 | 1994 | 403 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1422 | 0.020 |
Why?
|
Femur Head Necrosis | 1 | 1991 | 132 | 0.020 |
Why?
|
Infertility, Female | 1 | 1997 | 760 | 0.020 |
Why?
|
Spermatozoa | 1 | 1995 | 630 | 0.020 |
Why?
|
Angiotensins | 1 | 2011 | 143 | 0.020 |
Why?
|
Postoperative Care | 1 | 2017 | 1468 | 0.020 |
Why?
|
Th1 Cells | 1 | 1995 | 1036 | 0.020 |
Why?
|
Chronic Disease | 2 | 2023 | 9318 | 0.020 |
Why?
|
Respiration, Artificial | 2 | 2015 | 2628 | 0.020 |
Why?
|
Critical Care | 2 | 2015 | 2696 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2012 | 12148 | 0.020 |
Why?
|
Th2 Cells | 1 | 1995 | 1060 | 0.020 |
Why?
|
Glycosides | 1 | 2010 | 100 | 0.020 |
Why?
|
Homes for the Aged | 1 | 1992 | 272 | 0.020 |
Why?
|
Survival | 1 | 2010 | 161 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1403 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2011 | 294 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4174 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1408 | 0.020 |
Why?
|
Home Care Services | 1 | 1996 | 648 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 362 | 0.020 |
Why?
|
Radioligand Assay | 2 | 2001 | 366 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2009 | 197 | 0.020 |
Why?
|
Exercise Therapy | 1 | 1996 | 929 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1994 | 589 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 14666 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1408 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 1994 | 804 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 413 | 0.020 |
Why?
|
Renin | 1 | 2011 | 641 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7396 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2901 | 0.020 |
Why?
|
Confidentiality | 1 | 2013 | 609 | 0.020 |
Why?
|
Catheterization | 2 | 2007 | 1428 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2143 | 0.020 |
Why?
|
Gene Dosage | 1 | 2013 | 1217 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2018 | 1428 | 0.020 |
Why?
|
Child Behavior | 1 | 1994 | 847 | 0.020 |
Why?
|
Infertility | 1 | 1995 | 654 | 0.020 |
Why?
|
Orgasm | 1 | 2007 | 61 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1835 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 1096 | 0.020 |
Why?
|
Kainic Acid | 2 | 1998 | 203 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2007 | 37 | 0.020 |
Why?
|
Lens Capsule, Crystalline | 1 | 1987 | 39 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2013 | 783 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 931 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2254 | 0.020 |
Why?
|
Syndrome | 2 | 2007 | 3267 | 0.020 |
Why?
|
Mandatory Reporting | 1 | 2007 | 123 | 0.020 |
Why?
|
Hospital Costs | 1 | 2012 | 947 | 0.020 |
Why?
|
Gas Poisoning | 1 | 1986 | 5 | 0.020 |
Why?
|
Models, Statistical | 2 | 2005 | 5079 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7212 | 0.020 |
Why?
|
Pupil | 1 | 1987 | 146 | 0.020 |
Why?
|
Schools, Medical | 1 | 2013 | 879 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1722 | 0.020 |
Why?
|
Software | 1 | 2020 | 4434 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1881 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3422 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2477 | 0.020 |
Why?
|
HIV Seronegativity | 2 | 1997 | 211 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 803 | 0.020 |
Why?
|
New York | 1 | 2007 | 874 | 0.020 |
Why?
|
Aged, 80 and over | 7 | 2007 | 58976 | 0.020 |
Why?
|
Vitreous Body | 1 | 1987 | 399 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2957 | 0.020 |
Why?
|
Klebsiella pneumoniae | 1 | 2007 | 250 | 0.010 |
Why?
|
Nursing Homes | 1 | 1992 | 1082 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1033 | 0.010 |
Why?
|
Anesthesia | 1 | 1995 | 1594 | 0.010 |
Why?
|
Regression Analysis | 2 | 2010 | 6343 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4111 | 0.010 |
Why?
|
Acute Disease | 2 | 2011 | 7237 | 0.010 |
Why?
|
Postoperative Period | 1 | 2009 | 1813 | 0.010 |
Why?
|
Hypotension | 2 | 2000 | 879 | 0.010 |
Why?
|
Muscle Hypotonia | 1 | 2005 | 161 | 0.010 |
Why?
|
Counterpulsation | 1 | 2003 | 16 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1995 | 1922 | 0.010 |
Why?
|
Weight Gain | 1 | 2014 | 2348 | 0.010 |
Why?
|
Single-Blind Method | 2 | 2000 | 1572 | 0.010 |
Why?
|
HIV Infections | 3 | 1995 | 17351 | 0.010 |
Why?
|
Oklahoma | 1 | 2003 | 36 | 0.010 |
Why?
|
Southwestern United States | 1 | 2003 | 39 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6055 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
Body Weight | 2 | 2010 | 4618 | 0.010 |
Why?
|
Thalassemia | 2 | 1995 | 267 | 0.010 |
Why?
|
Sex Factors | 3 | 2008 | 10552 | 0.010 |
Why?
|
Family | 1 | 1994 | 3194 | 0.010 |
Why?
|
Skin Tests | 2 | 1995 | 637 | 0.010 |
Why?
|
Medical History Taking | 1 | 2006 | 774 | 0.010 |
Why?
|
Sample Size | 1 | 2006 | 841 | 0.010 |
Why?
|
Smoking | 2 | 1998 | 9053 | 0.010 |
Why?
|
Smoke | 1 | 2003 | 235 | 0.010 |
Why?
|
Belgium | 1 | 2001 | 118 | 0.010 |
Why?
|
Selection Bias | 1 | 2003 | 359 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2176 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2012 | 2775 | 0.010 |
Why?
|
Eye Diseases | 1 | 1987 | 653 | 0.010 |
Why?
|
Air Pollution | 1 | 1995 | 2359 | 0.010 |
Why?
|
Menopause | 1 | 1989 | 1646 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 2000 | 40 | 0.010 |
Why?
|
New Zealand | 1 | 2001 | 358 | 0.010 |
Why?
|
Cues | 1 | 1986 | 875 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2024 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2005 | 751 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1992 | 3575 | 0.010 |
Why?
|
Risk | 2 | 1995 | 9610 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 2 | 1997 | 2571 | 0.010 |
Why?
|
Birth Weight | 2 | 2001 | 2103 | 0.010 |
Why?
|
Hemoglobins | 2 | 1998 | 1525 | 0.010 |
Why?
|
New England | 1 | 2003 | 1054 | 0.010 |
Why?
|
Raphe Nuclei | 1 | 2000 | 103 | 0.010 |
Why?
|
Indians, North American | 1 | 2003 | 352 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2678 | 0.010 |
Why?
|
Cephalometry | 1 | 2001 | 382 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5492 | 0.010 |
Why?
|
Reaction Time | 1 | 1986 | 2082 | 0.010 |
Why?
|
Fever | 1 | 2007 | 1618 | 0.010 |
Why?
|
Visual Fields | 1 | 1986 | 1062 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2007 | 1277 | 0.010 |
Why?
|
Leukocytosis | 1 | 2000 | 251 | 0.010 |
Why?
|
Tritium | 1 | 1998 | 708 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4431 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7827 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3415 | 0.010 |
Why?
|
Brazil | 1 | 2001 | 1230 | 0.010 |
Why?
|
Ethanol | 1 | 2003 | 1324 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 1998 | 135 | 0.010 |
Why?
|
Insurance, Health | 1 | 2009 | 2498 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.010 |
Why?
|
Genomics | 1 | 2013 | 5821 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2273 | 0.010 |
Why?
|
Age Determination by Skeleton | 1 | 1997 | 126 | 0.010 |
Why?
|
Fallopian Tube Diseases | 1 | 1997 | 60 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2000 | 654 | 0.010 |
Why?
|
Hysteroscopy | 1 | 1997 | 62 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20570 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5972 | 0.010 |
Why?
|
Uterine Diseases | 1 | 1997 | 108 | 0.010 |
Why?
|
Medicaid | 1 | 2009 | 2818 | 0.010 |
Why?
|
beta Carotene | 1 | 1997 | 523 | 0.010 |
Why?
|
Hemarthrosis | 1 | 1995 | 39 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168459 | 0.010 |
Why?
|
Swine | 1 | 2005 | 5915 | 0.010 |
Why?
|
Life Tables | 1 | 1995 | 364 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2005 | 2727 | 0.010 |
Why?
|
Respiratory System | 1 | 1998 | 563 | 0.010 |
Why?
|
Naloxone | 1 | 1998 | 370 | 0.010 |
Why?
|
Aspirin | 1 | 2007 | 3133 | 0.010 |
Why?
|
Heart | 1 | 2008 | 4404 | 0.010 |
Why?
|
Testosterone | 2 | 1997 | 2472 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 1995 | 85 | 0.010 |
Why?
|
Splenic Diseases | 1 | 1995 | 90 | 0.010 |
Why?
|
Videotape Recording | 1 | 1996 | 337 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 1995 | 490 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6766 | 0.010 |
Why?
|
Apgar Score | 1 | 1994 | 126 | 0.010 |
Why?
|
Jaundice, Neonatal | 1 | 1994 | 71 | 0.010 |
Why?
|
Extremities | 1 | 2000 | 867 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 1994 | 157 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2011 | 4811 | 0.010 |
Why?
|
Sperm Count | 1 | 1995 | 229 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1994 | 340 | 0.010 |
Why?
|
Erythrocytes, Abnormal | 1 | 1994 | 121 | 0.010 |
Why?
|
Mathematics | 1 | 1995 | 707 | 0.010 |
Why?
|
Erythrocyte Indices | 1 | 1994 | 144 | 0.010 |
Why?
|
Meningitis | 1 | 1995 | 217 | 0.010 |
Why?
|
Sperm Motility | 1 | 1995 | 266 | 0.010 |
Why?
|
Reticulocytes | 1 | 1994 | 289 | 0.010 |
Why?
|
Myocardium | 1 | 2006 | 4726 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2265 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2414 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1992 | 21012 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1998 | 1007 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1994 | 310 | 0.010 |
Why?
|
Nicotine | 1 | 1998 | 680 | 0.010 |
Why?
|
Arousal | 1 | 1998 | 1166 | 0.010 |
Why?
|
Skull | 1 | 1997 | 818 | 0.010 |
Why?
|
Pain | 2 | 2000 | 5073 | 0.010 |
Why?
|
Bilirubin | 1 | 1994 | 436 | 0.010 |
Why?
|
Sexual Maturation | 1 | 1994 | 261 | 0.010 |
Why?
|
Anesthesia, Conduction | 1 | 1995 | 262 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1998 | 882 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1995 | 978 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1994 | 345 | 0.010 |
Why?
|
Platelet Count | 1 | 1994 | 781 | 0.010 |
Why?
|
Hemoglobin, Sickle | 1 | 1991 | 113 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4948 | 0.010 |
Why?
|
Population Surveillance | 1 | 2001 | 2598 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2003 | 2518 | 0.010 |
Why?
|
Education | 1 | 1994 | 537 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1994 | 853 | 0.010 |
Why?
|
Respiratory Sounds | 1 | 1995 | 702 | 0.010 |
Why?
|
Chest Pain | 1 | 1998 | 1091 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1995 | 565 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1997 | 1168 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1994 | 1596 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1995 | 596 | 0.010 |
Why?
|
Anemia | 1 | 2000 | 1509 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1995 | 1560 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1997 | 1934 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 1996 | 1410 | 0.000 |
Why?
|
Antigens | 1 | 1994 | 1443 | 0.000 |
Why?
|
Anesthesia, General | 1 | 1995 | 1174 | 0.000 |
Why?
|
Disease Susceptibility | 1 | 1995 | 1787 | 0.000 |
Why?
|
Affect | 1 | 1996 | 1486 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1989 | 11742 | 0.000 |
Why?
|
Recurrence | 1 | 2000 | 8465 | 0.000 |
Why?
|
Program Evaluation | 1 | 1996 | 2495 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15500 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8708 | 0.000 |
Why?
|
Range of Motion, Articular | 1 | 1993 | 1588 | 0.000 |
Why?
|
Lymphocytes | 1 | 1994 | 2612 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2006 | 7879 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2005 | 18252 | 0.000 |
Why?
|
Patient Compliance | 1 | 1996 | 2690 | 0.000 |
Why?
|
Vaccines | 1 | 1994 | 844 | 0.000 |
Why?
|
Lung Diseases | 1 | 1995 | 1909 | 0.000 |
Why?
|
Laparoscopy | 1 | 1997 | 2035 | 0.000 |
Why?
|
Patient Admission | 1 | 1992 | 1367 | 0.000 |
Why?
|
Schools | 1 | 1994 | 1489 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 2395 | 0.000 |
Why?
|
Tamoxifen | 1 | 1989 | 965 | 0.000 |
Why?
|
Prednisone | 1 | 1989 | 1563 | 0.000 |
Why?
|
Fluorouracil | 1 | 1989 | 1641 | 0.000 |
Why?
|
Hypertension | 1 | 2004 | 8540 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1989 | 2218 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1995 | 4369 | 0.000 |
Why?
|
Methotrexate | 1 | 1989 | 1719 | 0.000 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1995 | 4580 | 0.000 |
Why?
|
Radiography | 1 | 1993 | 6965 | 0.000 |
Why?
|
Mental Health | 1 | 1996 | 3250 | 0.000 |
Why?
|
Rats | 1 | 1998 | 23742 | 0.000 |
Why?
|
Receptors, Estrogen | 1 | 1989 | 2208 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 1994 | 2947 | 0.000 |
Why?
|
Inflammation | 1 | 2000 | 10773 | 0.000 |
Why?
|
Massachusetts | 1 | 1992 | 8830 | 0.000 |
Why?
|